All Activity

Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. 대구 출장마사지 Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. slot gacor Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. bandar slot gacor Great job for publishing such a beneficial web site. Your web log isn’t only useful but it is additionally really creative too. 給湯器交換 おすすめ

Укажите наш промокод 1xBet – 1X200NUT и выберите приветственный бонус. 1хбет промокод при регистрации

I found that site very usefull and this survey is very cirious, I ' ve never seen a blog that demand a survey for this actions, very curious... 대구 출장마사지 I found that site very usefull and this survey is very cirious, I ' ve never seen a blog that demand a survey for this actions, very curious... slot depo 5k I found that site very usefull and this survey is very cirious, I ' ve never seen a blog that demand a survey for this actions, very curious... slot gacor I found that site very usefull and this survey is very cirious, I ' ve never seen a blog that demand a survey for this actions, very curious... エコキュート 補助金

Most other states allow people to grow their own marijuana at home, particularly medical marijuana users, while New Jersey still fully bans it. By Sophie Nieto-Muñoz, New Jersey Monitor New Jersey’s steep decline in medical marijuana patients continued with another 20 percent drop since the beginning of 2025. Between January and December, roughly 14,000 people let their medical marijuana registration lapse, a trend that has continued since the recreational market launched in April 2022. As of mid-December, 51,776 people are registered medical marijuana patients, according to the state Cannabis Regulatory Commission. In June 2022, that figure was nearly 130,000. Medical marijuana cardholders get some benefits. Dispensaries hold patient-only hours, give patients special parking, and let them skip ahead of recreational users in line. Patients also avoid paying cannabis taxes and can purchase up to 3 ounces of cannabis per month. Before the recreational market opened, patients were the only New Jerseyans who could legally buy marijuana. In recent years, officials have attempted to attract people back to the medical program by dropping the price of a registration card from $200 to $10 (there’s also a free digital option). People must also obtain a card from doctors who qualify to write medical cannabis prescriptions for treatment of conditions like epilepsy, post-traumatic stress disorder, anxiety, cancer and more. The drop in enrollment has reflected the trends other states have seen when launching adult-use weed. But most other states allow people to grow their own marijuana at home, particularly medical marijuana users, while New Jersey still fully bans it. This story was first published by New Jersey Monitor. The post New Jersey Medical Marijuana Program Sees Steep Drop In Registered Patients appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A Florida Republican senator has filed a bill to expand the state’s medical marijuana program, in part by increasing supply limits for patients and waiving registration fees for honorably discharged military veterans. The legislation from Sen. Alexis Calatayud (R), filed for the 2026 session on Tuesday, would also make it so medical cannabis registrations could last up to two years instead of the current 30 weeks. Another section of the bill stipulates that doctors could certify patients to receive up to 10 70-day supply limits of smokable medical marijuana, rather than three. They could also issue up to 20 35-day supply limits instead of the current six. A similar version of legislation was introduced in the House by Rep. Bill Partington (R) earlier this month. That bill additionally called for reciprocity in the program, requiring regulators to create a process to issue medical cannabis registration cards to “nonresidents who are actively enrolled in the medical cannabis program of another jurisdiction recognized by the department within 1 business day.” It specifies that “a visiting qualified patient may engage in all conduct authorized for a qualified patient.” It would also allow doctors to recommend cannabis to any patient who has a condition for which they have been prescribed opioids. Another provision of the House bill absent from the new Senate version would allow doctors to recommend medical cannabis via telehealth without a physical examination—expanding a current policy that allows renewals, but not initial certifications, to be conducted remotely. Other recently filed bills in the legislature for 2026 would reduce medical cannabis patient registration fees for military veterans and clarify that smoking or vaping marijuana in public places is prohibited. Meanwhile, a Florida Democratic senator introduced legislation for the 2026 session that would legalize home cultivation of marijuana for registered medical cannabis patients in the state. The proposal would permit qualified patients who are at least 21 years old to cultivate up to six flowering plants for personal, therapeutic use. Those patients could also buy seeds and clones from licensed dispensaries. If enacted into law, the bill would become law on July 1, 2026. A similar proposal was introduced at the beginning of this year by Sen. Joe Gruters (R), who is now chairman of the Republican National Committee, but it did not advance. Gruters and Kim Rivers—the CEO of Trulieve, a medical marijuana company that provided the bulk of funding for an unsuccessful cannabis legalization ballot initiative last year—also met with President Donald Trump ahead of his endorsement of the constitutional amendment, as well as federal rescheduling and industry banking access. The campaign behind that initiative, Smart & Safe Florida, recently said it’s collected more than one million signatures to put a new version of the legalization measure on the 2026 ballot. But the signature gathering process has hit multiple snags that have led to litigation, including a new lawsuit filed by activists challenging the state’s decision to invalidate another 71,000 signatures over issues related to “inactive” voters and out-of-state petitioners. This comes after another court upheld a previous decision to strike about 200,000 signatures that the state said were invalid because the petitions didn’t include the full text of the proposed initiative. The campaign contested the legal interpretation, but it declined to appeal the decision based on their confidence they’d collected enough signatures to make up the difference. Now, with a February 1 deadline to submit 880,062 valid signatures just about a month away, Smart & Safe Florida is signaling that the additional invalidations could jeopardize their chances of making the ballot. Currently, the state has validated 675,307 signatures. Meanwhile, earlier this month, Florida’s attorney general asked the state Supreme Court to review the constitutionality of the legalization initiative. The court accepted the request and set a schedule for state officials and the cannabis campaign to file briefs next month. Florida Gov. Ron DeSantis (R) campaigned heavily against an earlier version of the legalization proposal, which received a majority of voters last year but not enough to meet the 60 percent threshold required to pass a constitutional amendment. Former Attorney General Ashley Moody (R) unsuccessfully contested the prior initiative in the courts. In March, meanwhile, two Democratic members of Congress representing Florida asked the federal government to investigate what they described as “potentially unlawful diversion” of millions in state Medicaid funds via a group with ties to Gov. Ron DeSantis (R). The money was used to fight against a citizen ballot initiative, vehemently opposed by the governor, that would have legalized marijuana for adults. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In the background, a recent poll from a Trump-affiliated research firm found that nearly 9 in 10 Florida voters say they should have the right to decide to legalize marijuana in the state. Meanwhile, a pro-legalization GOP state lawmaker recently filed a bill to amend state law to codify that the public use of marijuana is prohibited. Rep. Alex Andrade (R), the sponsor, said earlier this year that embracing cannabis reform is a way for the Republican party to secure more votes from young people. Separately, Florida medical marijuana officials are actively revoking the registrations of patients and caregivers with drug-related criminal records. The policy is part of broad budget legislation signed into law earlier this year by DeSantis. The provisions in question direct the state Department of Health (DOH) to cancel registrations of medical marijuana patients and caregivers if they’re convicted of—or plead guilty or no contest to—criminal drug charges. Photo courtesy of Brian Shamblen. The post Florida GOP Senator’s Bill Would Expand Medical Marijuana Law By Waiving Fees For Veterans And Making Patient Cards Last Twice As Long appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“The [2023] ballot initiative had absolutely zero effect on anything in the hemp industry. But it sounds like that’s the vast majority of what people want to overturn.” By Nick Evans, Ohio Capital Journal Ohioans for Cannabis Choice is mounting a referendum effort against a new law cracking down on intoxicating hemp and making several changes to Ohio’s voter-passed recreational marijuana law. If its signature gathering effort proves successful, Ohio voters will be asked whether to reject provisions of Ohio Senate Bill 56 next November. They’ll need to collect almost 250,000 signatures to put that question on the ballot. Ohio voters approved adult-use marijuana at the ballot box in November 2023. State lawmakers have been wrestling with changes to that law ever since. Wesley Bryant, the owner of 420 Craft Beverages in Cleveland and one of the petitioners leading the referendum campaign, called lawmakers’ recent changes “a slap in the face to voters who overwhelmingly voted to legalize cannabis in 2023.” What’s in the bill Among S.B. 56’s changes, lawmakers capped marijuana potency, prohibited smoking in most public places, and imposed penalties on smoking in vehicles—as a driver or a passenger. Bringing legally purchased marijuana into Ohio from another stat would become illegal and Ohioans would face criminal penalties if they exceeded limits on homegrown cannabis. The new law also eliminates anti-discrimination provisions related to housing, employment, and organ donation. But perhaps the biggest change for Ohio’s marijuana industry is language banning intoxicating hemp outside of a licensed cannabis dispensary. Those products start from cannabis plants with very little naturally occurring THC and then alter other compounds in a laboratory setting to create more of the chemical that makes users feel high. The prohibition brings Ohio in line with recent changes to federal law. Gov. Mike DeWine (R) has been complaining for almost two years about the proliferation of intoxicating hemp products like gummies made to look like popular candy brands or other snacks. By signing S.B. 56 those products become illegal in March. Notably, state lawmakers had thrown a lifeline to the state’s booming THC beverage industry. The bill that arrived on DeWine’s desk would’ve allowed beverages with up to 5 milligrams of THC to be produced and sold in Ohio until the end of 2026, when federal law kicks in and they become illegal. Instead, DeWine issued a line-item veto effectively prohibiting them in March along with other intoxicating hemp products. The referendum Ohioans for Cannabis Choice quickly announced plans for the referendum and filed its initial batch of signatures a little more than a week after DeWine signed the legislation. “In filing our petitions today,” Bryant said in a statement, “We are taking a stand for Ohioans against politicians in Columbus and saying no to the government overreach of S.B. 56.” With petitions delivered, state officials are on the clock. The Secretary of State has 10 business days to verify the signatures, and the Attorney General has the same amount of time to certify the petition summary is fair and truthful. If the petition clears those bars, organizers can begin canvassing to collect signatures. They’ll need 6 percent of the total number of votes cast in the most recent gubernatorial election (248,092). The group will also need 3 percent of an individual county’s gubernatorial turnout in 44 of Ohio’s 88 counties. Organizers will have 90 days from the date the governor filed the law with the secretary to collect the require signatures. Another petitioner, Tuscarawas County hemp farmer Joseph Ellwood, said ordinary Ohioans weren’t asking for changes lawmakers made. “Ohioans oppose re-criminalizing cannabis,” he said. “For example, making it a crime to grow more than six plants, a crime to have unauthorized paraphernalia, and a crime to buy marijuana in Michigan and bring it home.” “And this is just the start,” Ellwood added. “Politicians in Columbus won’t stop until marijuana and hemp are completely illegal in Ohio again.” Andrew Greene, the group’s third petitioner and an employee at a Dayton distribution center, said numerous jobs are at stake if S.B. 56 takes effect. “There are thousands of workers like me who are going to lose their jobs because S.B. 56 will close more than 6,000 small businesses across Ohio,” Greene said. “It’s sad because the cannabis industry, both hemp and marijuana, support legislation that will protect consumers and strengthen Ohio farmers and small businesses,” he went on, “But these out-of-touch politicians are hell bent on re-criminalizing marijuana and hemp products.” Reactions The measure’s sponsor, state Sen. Steve Huffman, R-Tipp City, expressed some sympathy for those frustrated with the bill, but portrayed several provisions as clarifications rather than wholesale changes. He pointed to the number of plants allowed for home growers as an example. “We clarified the number of plants—six for one person, six for the other—that didn’t change,” he said of the 12-plant household limit. “But the way the ballot initiative was, you weren’t allowed to be prosecuted till 23 [plants] which really didn’t make sense, and 12 seemed to be what was intended, and we went with that.” Lawmakers improved the expungement process, he added, and did work behind the scenes to hopefully streamline licensing and regulation for business owners. And Huffman questioned the motives of those behind the referendum. Although Ohio voters approved adult-use marijuana, he said, much of the pushback against his bill seems to be coming from the hemp industry. “The [2023] ballot initiative had absolutely zero effect on anything in the hemp industry,” Huffman said. “But it sounds like that’s the vast majority of what people want to overturn.” “There’s some contradiction there,” he added. DeWine spokesman Dan Tierney made a similar point. While he stressed it’s the right of any Ohio citizen to pursue a referendum, the organizers’ claim that S.B. 56 goes against the will of the voters is “inconsistent.” The 2023 ballot measure could’ve allowed marijuana sales anywhere, Tierney said, but it didn’t. And so seeking a referendum to protect the sale of THC infused beverages in bars or convenience stores doesn’t protect the will of the voters. This story was first published by Ohio Capital Journal. The post Ohio Governor And GOP Senator Criticize Activists Pushing Referendum To Reverse Marijuana And Hemp Restrictions appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

An agriculture-focused conservative nonprofit connected to a PAC linked to President Donald Trump is applauding his recent marijuana rescheduling order, arguing that it will “destroy” the illicit market and support seniors and military veterans who could benefit from cannabis. America First Agriculture Inc.—a group affiliated with a PAC of a similar name that previously urged Trump to follow through on a campaign pledge to reschedule marijuana—said in a new ad that the president “promised to put America first, and his word is as good as gold.” “Trump delivered a secure border, unleashed American energy and provided the largest tax cut in American history. Now Trump has delivered again by rescheduling cannabis, which was classified as more dangerous than fentanyl,” it said. “Trump’s action will destroy the cartel’s illicit black market, expand medical research and ensure seniors and veterans safely receive the care they need,” the ad continued. “Thank President Trump for delivering on another America First promise.” When President Trump makes a promise, his word is gold. Trump delivered again by rescheduling cannabis. This new America First win will destroy the cartel's black market, expand medical research, and ensure seniors and veterans receive needed care. Thank you, President Trump! pic.twitter.com/No8YYXesXy — America First Agriculture Inc. (@amfirstaginc) December 19, 2025 The description of the impact of the executive order is somewhat exaggerated, in part because it suggests the rescheduling deal is done. In reality, the order directs the attorney general to expeditiously complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). The Justice Department has not given a timeline for when that might happen, and congressional researchers recently pointed out that it’s possible the agency could start the process over again, or decline to move forward all together. But even if and when the process is finalized, it’s unclear how that would “destroy” the illicit market. Rescheduling cannabis wouldn’t federally legalize it, which advocates have argued would be necessary in order to meaningfully disrupt illegal sales. The tax parity impact of moving marijuana to Schedule III is one of the more significant reasons industry stakeholders have been pushing for the incremental reform, even if it doesn’t immediately legalize cannabis. Beyond that, a Schedule III designation would symbolically recognize the plant’s medical value and loosen certain research restrictions tied to Schedule I drugs. Notably, the organization behind the new ad is associated with the similarly named America First Agriculture Action Inc., a PAC that lists Charles Gantt as its treasurer. Gantt is also the treasurer of Trump’s own political committee, MAGA Inc., which reported receiving $1 million from a marijuana industry PAC that’s supported by multiple major cannabis companies. That committee, the American Rights and Reform PAC, separately released ads in May that attacked former President Joe Biden’s marijuana policy record in an apparent attempt to push Trump to go further on the issue. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a coalition of Republican state attorneys general are criticizing Trump’s decision to federally reschedule marijuana, saying cannabis is “properly” classified as a Schedule I drug with no accepted medical use and a high potential for abuse. Earlier this month, groups of House and Senate Republican lawmakers also sent letters urging Trump not to reschedule cannabis. Trump, however, dismissed those concerns—pointing out that an overwhelming majority of Americans support the reform and that cannabis can help people who are suffering from serious health issues, including his personal friends. The post Group With Ties To Trump-Linked PAC Applauds Marijuana Rescheduling Move In New Ad, Saying It’ll Help Veterans And ‘Destroy’ Illicit Market appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The top Pennsylvania House lawmaker says legalizing marijuana is one way to create a “very important” revenue source for the state, and it’s an achievable reform if only legislators could find “the will to do it.” In an interview with City & State that was published on Monday, House Speaker Joanna McClinton (D) was asked about the need to bolster revenue and what options might be on the table heading into the 2026 session. “It’s very important. When we talk about the needs for schools, for transit, for roads and bridges, we have to have a way to pay for everything—not just today, but in three years, in six years,” she said. “The only way we can do that is by creating new revenue.” “Some of the ways the governor requested that we create the revenue was through legalizing marijuana, raising the minimum wage, regulating skill games. So we have ways to do it,” the speaker said. “We’ve sent some of those to the Senate, but we haven’t been able to get any of those bills to the governor’s desk.” To that point, the House passed a marijuana legalization bill earlier this year, with a novel proposal to have sales take place at state-run stores, but it was promptly rejected by the GOP-controlled Senate. “I think any of [the revenue options] would be palatable; we just have to have the will to do it. We should do them all,” McClinton said. “We should raise the minimum wage. We should legalize cannabis. We should regulate skill games. We should do them all, because we don’t want to get to a point where we were when I entered into the legislature in 2015 where the deficit was astonishing and large and vast.” Bipartisan Pennsylvania lawmakers who’ve been working to enact adult-use legalization over recent sessions without success so far have also recently said that President Donald Trump’s federal marijuana rescheduling order could grease the wheels in the new year. “I think that having President Trump, in particular, sign this executive order really gives permission for a lot of Republican lawmakers who may have been reticent about actually admitting that they supported it some cover to be able to actually support it,” Rep. Emily Kinkead (D) said. “I am even more optimistic than I was that we are going to get legalization of recreational cannabis done in Pennsylvania in 2026.” Rep. Dan Frankel (D), chair of the House Health Committee and another champion of reform in the legislature, also said the rescheduling move will “bolster the existing medical marijuana marketplace.” While there may be some disagreement among lawmakers about rescheduling or broader reform, Trump’s executive order marks a “step toward common-sense drug policy reform,” Sen. Dan Laughlin (R) said. For what it’s worth, another top GOP senator—Sen. Scott Martin (R), chair of the chamber’s Appropriations Committee—said earlier this month that he was skeptical about the prospects of enacting legalization in the 2026 session, in part because of the federal classification of cannabis that’s now expected to change. Of course, marijuana would still be federally illegal under Schedule III, so it’s unclear if a simple loosening of the law would move the needle enough from his perspective. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — A top aide to Pennsylvania’s governor said in September that lawmakers should stop introducing new competing legalization bills and instead focus on building consensus on the issue—while emphasizing that any measure that advances needs to contain equity provisions if the governor is going to sign it into law. Laughlin, for his part, said in August that the House “needs to pass the language in my bill and send it to my committee” after which point he “can negotiate with the Senate and the governor.” The senator separately said recently that supporters are “picking up votes” to enact the reform this session. Meanwhile, bipartisan Pennsylvania senators in October introduced a bill that would allow terminally ill patients to use of medical marijuana in hospitals. Separately, the leading Republican candidate in the race to become the next governor of Pennsylvania dodged a question about her stance on legalizing marijuana—saying she doesn’t have a “policy position” on the issue and arguing that the sitting governor’s proposal for reform “way, way overstated” potential revenue. The candidate, Pennsylvania Treasurer Stacy Garrity (R), pointed to neighboring Ohio, which launched its own adult-use cannabis market this year, saying “they generated about $115 million in revenue.” And while the populations of both states are relatively comparable, Shapiro’s budget projected $536.5 million in cannabis revenue in the first fiscal year of implementation. She did, however, say that if Pennsylvania moves forward on enacting the reform, she’ll “make sure that it’s banked appropriately.” Meanwhile, a Pennsylvania Democratic senator recently said that federal marijuana rescheduling would be “very influential” in advancing legalization in his state, giving “political cover” to GOP members on the fence about reform. Polls have shown bipartisan support for legalization among voters, but the reform has consistently stalled in the legislature, due largely to GOP opposition. But not all Republican members are against the policy change—and one recently said she felt her party should seize the “opportunity to snatch” the issue from Democrats. Photo courtesy of Chris Wallis // Side Pocket Images. The post Marijuana Legalization Could Boost Pennsylvania’s Revenue, House Speaker Says, If Only Senate Could Find ‘The Will To Do It’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Terrific short article. All the content has an affect on a large amount of emergency worries of our population. Everyone can not be uninvolved to make sure you all of these worries. This approach content gives you plans and additionally techniques. Particularly revealing and additionally effective. taxis in Nerja

Great post. The particular submit has an effect on plenty of important difficulties individuals community. We all can't be uninvolved to be able to these kinds of difficulties. This kind of submit offers guidelines and also principles. Extremely useful and also sensible. Apartamentos Turísticos Nerja

TX hemp rules; FL legalization lawsuit; CA marijuana research grants; Study: DUI laws jail innocent cannabis users; Biggest marijuana stories of 2025 Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Ohio cannabis activists submitted an initial batch of signatures to put a referendum on the ballot that would allow voters to reverse lawmakers’ move to roll back marijuana legalization and restrict hemp products. A Florida marijuana campaign filed another lawsuit challenging state officials’ moves to invalidate more than 70,000 signatures in support of a legalization initiative it hopes to place on the 2026 ballot. The Texas Department of State Health Services filed proposed hemp product rules covering age-gating, licensing fees, testing requirements, packaging restrictions and more. The proposal would also shift hemp to a total THC standard, rather than the current one that limits delta-9 THC content alone, which advocates say will eliminate some popular products from the market. The California Department of Cannabis Control awarded nearly $30 million in marijuana revenue-funded grants to support research on the effects of THC beverages, the therapeutic potential of novel cannabinoids, how compounds like terpenes affect product flavoring, tribal participation in the legal market and other issues. Marijuana Moment compiled an overview of the biggest cannabis developments of 2025—from President Donald Trump’s rescheduling order to Supreme Court action and developments on the state level that both built momentum for legalization and threatened to reverse gains already achieved. A new government-funded study on impaired driving laws found that “many regular users of cannabis exceed zero tolerance and per se THC cutpoint concentrations days after their last use, risking legal consequences despite no evidence of impairment.” “Cannabis blood limit laws lack scientific credibility and are not an accurate determinant of when drivers should face criminal charges or not.” Colorado Gov. Jared Polis (D) is touting the state’s nearly $1 billion in marijuana sales this year, saying the legal industry “drives out criminals and cartels and is supporting Colorado businesses and jobs while driving revenue for school construction.” / FEDERAL The Government Accountability Office published a report on the illicit synthetic drugs market. Rep. Greg Steube (R-FL) tweeted, “Rescheduling marijuana doesn’t mean legalization, but it allows us to responsibly explore the medicinal value of cannabis so we can help our fellow Americans, especially our veterans, struggling with severe pain and sickness. That’s why I have championed this cause with my Marijuana 1-to-3 Act since my very first term in Washington. President Trump made the right call. Now it’s time for Congress to step up and do its part.” / STATES Minnesota Gov. Tim Walz (D) signed a cannabis compact with the Bois Forte Band of Chippewa. Wyoming’s House speaker said he doesn’t believe there is an “appetite” in the state for marijuana reform despite President Donald Trump’s move toward federal rescheduling. A Kansas senator said President Donald Trump’s marijuana rescheduling order is an “ignorant and dangerous move.” Colorado regulators published guidance about potential federal marijuana rescheduling. Michigan regulators published guidance on annual financial statements that need to be filed by marijuana businesses. Massachusetts regulators are considering downgrading cannabis cultivators to lower license tiers. Vermont regulators are accepting enrollments for a marijuana budtender education class. Washington State regulators posted a presentation on cannabis consumer education. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL The Bosnia and Herzegovina Council of Ministers approved a proposal to legalize medical cannabis. / SCIENCE & HEALTH A study found that “C.sativa can be considered as an effective drug in curing diseases caused by bacteria.” A study found that “younger women more frequently substituted THC [for alcohol] and were influenced by alcohol severity, poor health, and sleep disturbance, whereas older women substituted less often, with PTSD and sleep difficulties as key predictors.” / ADVOCACY, OPINION & ANALYSIS The Nebraska Cannabis Trade Alliance is a new organization focusing on launching the state’s voter-approved medical marijuana program. / BUSINESS IM Cannabis Corp. is exploring entry into the U.S. market following President Donald Trump’s marijuana rescheduling executive order. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Ohio petition could put cannabis back on the ballot (Newsletter: December 31, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. slot 4d Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. spaceman Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. miototo Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. slot toto Awesome and interesting article. Great things you've always shared with us. Thanks. Just continue composing this kind of post. togel sgp

Fantastic Put up, I'm sure a giant believer through post feed-back concerning webpages towards allow the blog page consultants recognise that they’ve further a specific thing positive towards the web! 火災保険 × 申請しないと損

Code promo 1Win tours gratuits 2026 : 1W2026VIP, les joueurs peuvent souvent recevoir des tours gratuits, un pourcentage augmenté du bonus sur dépôt et d'autres bonus. 1Win créditera automatiquement votre compte bonus avec un bonus de 500 %. Le bonus sans dépôt est l'une des récompenses les plus recherchées dans les paris sportifs en ligne et les casinos. Ce type de promotion permet aux joueurs de recevoir de l'argent gratuit, des tours gratuits ou des crédits de paris sans effectuer un dépôt initial code promo 1win gratuit aujourd hui

Pour aider à atténuer le risque, 1Win offre un bonus Cashback sur les paris perdus, où un pourcentage des pertes encourues — particulièrement sur les accumulateurs ou les paris à enjeux élevés — est remboursé soit sous forme de fonds bonus soit en argent réel. Ce bonus fournit un filet de sécurité qui adoucit l'impact d'un pari infructueux, encourageant les joueurs à continuer à parier en réduisant le risque financier associé à chaque pari code promo 1win abidjan

With thanks to get furnishing recently available posts in connection with the dilemma, I actually look ahead to learn extra. 火災保険 申請方法

Patterns become familiar, reactions Slice Master grow smoother, and timing feels more instinctive. Improvement feels earned through understanding rather than repetition alone.

A Florida campaign seeking to put marijuana legalization on the state’s 2026 ballot has filed a new lawsuit against state officials, alleging that they improperly directed the invalidation of about 71,000 signatures as a turn-in deadline quickly approaches. Smart & Safe Florida has been fighting several legal battles this cycle to ensure that its initiative is able to qualify for ballot placement. The latest lawsuit, filed in the Leon County circuit court on Monday, claims Secretary of State Cord Byrd (R) directed county election officials to invalidate about 42,000 signatures from so-called “inactive” voters and roughly 29,000 signatures collected by out-of-state petitioners. This comes after another court upheld a previous decision to strike about 200,000 signatures that the state said were invalid because the petitions didn’t include the full text of the proposed initiative. The campaign contested the legal interpretation, but it declined to appeal the decision based on their confidence they’d collected enough signatures to make up the difference. Now, with a February 1 deadline to submit 880,062 valid signatures just about a month away, Smart & Safe Florida is signaling that the additional invalidations could jeopardize their chances of making the ballot. Currently, the state has validated 675,307 signatures. “Time is of the essence,” the new lawsuit says, according to The News Service of Florida. “The Florida secretary of state has issued two unlawful directives that, unless stopped, will invalidate the citizen initiative petitions signed by more than 70,000 registered voters.” With respect to the “inactive” voters, the term refers to those who are registered but for whom mail is marked as undeliverable, resulting in their addresses being considered unconfirmed. This group can become unregistered if they don’t vote in two consecutive general elections. “The absurd result of the secretary’s directive is that ‘inactive’ voters can vote for the proposed amendment but cannot have their petitions counted to place the proposed amendment on the ballot to vote for it,” the lawsuit says. The out-of-state petitioner issue, meanwhile, is about the enforcement of a law passed earlier this year barring non-Florida residents from collecting signatures. Amid legal challenges, a federal court issued an injunction blocking its enforcement for about two months before that injunction was stayed by another judge. Smart & Safe Florida is arguing that signatures collected during the injunction window should not be invalidated, as they were lawfully obtained while the law was not in effect. Meanwhile, earlier this month, Florida’s attorney general asked the state Supreme Court to review the constitutionality of the legalization initiative. The court accepted the request and set a schedule for state officials and the cannabis campaign to file briefs next month. The campaign said last month that it’d collected more than one million signatures to put the cannabis measure on the ballot, but it’s also challenged officials at the state Supreme Court level over delays the certification process, arguing that the review of the ballot content and summary should have moving forward months ago when it reached an initial signature threshold. The state then agreed to move forward with the processing. Florida Gov. Ron DeSantis (R) campaigned heavily against an earlier version of the legalization proposal, which received a majority of voters last year but not enough to meet the 60 percent threshold required to pass a constitutional amendment. Former Attorney General Ashley Moody (R) unsuccessfully contested the prior initiative in the courts. In March, meanwhile, two Democratic members of Congress representing Florida asked the federal government to investigate what they described as “potentially unlawful diversion” of millions in state Medicaid funds via a group with ties to Gov. Ron DeSantis (R). The money was used to fight against a citizen ballot initiative, vehemently opposed by the governor, that would have legalized marijuana for adults. The lawmakers’ letter followed allegations that a $10 million donation from a state legal settlement was improperly made to the Hope Florida Foundation, which later sent the money to two political nonprofits, which in turn sent $8.5 million to a campaign opposing Amendment 3. The governor said in February that the newest marijuana legalization measure is in “big time trouble” with the state Supreme Court, predicting it will be blocked from going before voters next year. “There’s a lot of different perspectives on on marijuana,” DeSantis said. “It should not be in our Constitution. If you feel strongly about it, you have elections for the legislature. Go back candidates that you believe will be able to deliver what your vision is on that.” “But when you put these things in the Constitution—and I think, I mean, the way they wrote, there’s all kinds of things going on in here. I think it’s going to have big time trouble getting through the Florida Supreme Court,” he said. The latest initiative was filed with the secretary of state’s office just months after the initial version failed during the November 2024 election—despite an endorsement from President Donald Trump. Smart & Safe Florida is hoping the revised version will succeed in 2026. The campaign—which in the last election cycle received tens of millions of dollars from cannabis industry stakeholders, principally the multi-state operator Trulieve—incorporated certain changes into the new version that seem responsive to criticism opponents raised during the 2024 push. For example, it now specifically states that the “smoking and vaping of marijuana in any public place is prohibited.”Another section asserts that the legislature would need to approve rules dealing with the “regulation of the time, place, and manner of the public consumption of marijuana.” Last year, the governor accurately predicted that the 2024 cannabis measure from the campaign would survive a legal challenge from the state attorney general. It’s not entirely clear why he feels this version would face a different outcome. While there’s uncertainty around how the state’s highest court will navigate the measure, a poll released in February showed overwhelming bipartisan voter support for the reform—with 67 percent of Florida voters backing legalization, including 82 percent of Democrats, 66 percent of independents and 55 percent of Republicans. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In the background, a recent poll from a Trump-affiliated research firm found that nearly 9 in 10 Florida voters say they should have the right to decide to legalize marijuana in the state. Meanwhile, a pro-legalization GOP state lawmaker recently filed a bill to amend state law to codify that the public use of marijuana is prohibited. Rep. Alex Andrade (R), the sponsor, said earlier this year that embracing cannabis reform is a way for the Republican party to secure more votes from young people. Separately, Florida medical marijuana officials are actively revoking the registrations of patients and caregivers with drug-related criminal records. The policy is part of broad budget legislation signed into law earlier this year by DeSantis. The provisions in question direct the state Department of Health (DOH) to cancel registrations of medical marijuana patients and caregivers if they’re convicted of—or plead guilty or no contest to—criminal drug charges. Photo courtesy of Mike Latimer. The post Florida Marijuana Campaign Sues State Over Invalidation Of 71,000 Signatures With Turn-In Deadline Weeks Away appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“Colorado’s world-class marijuana industry drives out criminals and cartels and is supporting Colorado businesses and jobs while driving revenue for school construction.” By Elyse Apel, The Center Square In 2025, Coloradans spent upwards of $1 billion on legal marijuana. That generated almost $200 million in tax and fee revenue for the state, according to monthly data published by the Colorado Department of Revenue. By the end of the year, the department anticipates Colorado will surpass $1 billion in tax and fee revenue on marijuana sales. “Colorado’s world-class marijuana industry drives out criminals and cartels and is supporting Colorado businesses and jobs while driving revenue for school construction,” Colorado Gov. Jared Polis (D) posted on x.com. “This important milestone is one that our state can continue to build on.” Colorado has long been on the forefront of the legalization of marijuana. In 2012, it was the first state in the United States to approve the sale of licensed recreational marijuana. Since then, the state has brought in more than $3 billion dollars in tax and fee revenue from marijuana, while marijuana sales have topped nearly $18 billion. Heralded as a major revenue source for the state, its tax revenue has been used over the years to help fund infrastructure projects and public schools. Colorado’s world-class marijuana industry drives out criminals and cartels and is supporting Colorado businesses and jobs while driving revenue for school construction. This important milestone is one that our state can continue to build on. pic.twitter.com/BWvJxscLMG — Governor Jared Polis (@GovofCO) December 26, 2025 Currently, the state’s sales tax sits at 2.9 percent, the state retail marijuana sales tax at 15 percent, and the state retail marijuana excise tax at 15 percent. Federal policy has been slowly changing to reflect the legalization of marijuana in the majority of states. Just earlier this month, President Donald Trump signed an executive order on reclassifying marijuana from a Schedule I drug to a Schedule III drug. This signals a significant shift in the federal government’s stance on marijuana. “Decades of federal drug control policy have neglected marijuana’s medical uses,” the order said. “The federal government’s long delay in recognizing the medical use of marijuana does not serve the Americans who report health benefits from the medical use of marijuana to ease chronic pain and other various medically recognized ailments.” Polis applauded this decision, calling it “long overdue.” “It’s far past time for the federal government to catch up to Colorado and many other states and get rid of arcane federal policies on cannabis that aren’t based in reality and hurt Colorado small businesses and public safety,” he said. “For years Colorado has been a national leader in smart and safe cannabis policy that has virtually eliminated illegal markets, ensured safe use, and generated over a billion dollars for education. Colorado’s cannabis industry is the gold standard ensuring that products are safe and regulated.” Not everyone is happy with Trump’s order though, as concerns especially grow about high-potency THC products. “The Trump administration has declared a literal war on drugs, saying that fentanyl is a ‘weapon of mass destruction,’ while at the same time potentially making marijuana more accessible by loosening federal restrictions,” Tony Perkins, president of the Family Research Council, posted in response to the order on x.com. “Colorado, which legalized marijuana in 2012, has become a case study of the consequences: an increase in traffic deaths, mental health concerns, and emergency room visits, workplace safety issues, and a growth in the black market.” Complete data on Colorado marijuana sales from the year will be available in February. This story was first published by The Center Square. The post Colorado Governor Touts State’s $1 Billion In Legal Marijuana Sales This Year appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Laws aimed at preventing marijuana-impaired driving in almost 20 states are causing innocent people who show no signs of impairment to be criminalized and imprisoned for allegedly operating vehicles while under the influence, a new government-funded study shows. Lawmakers and regulators aiming to reduce drug-impaired driving have long sought to apply a familiar strategy from alcohol enforcement: setting a numerical limit of THC in the bloodstream beyond which a driver is presumed to be impaired, commonly referred to as a “per se” amount. But the new study suggests that approach may be badly misaligned with the science related to impairment from cannabis, the components and metabolites of which can remain in the body day or weeks after use—when impairment is no longer an issue. “Many regular users of cannabis exceed zero tolerance and per se THC cutpoint concentrations days after their last use, risking legal consequences despite no evidence of impairment,” the study, which was published in the scientific journal Clinical Chemistry and partially funded by the National Institutes of Health and the State of California, found. The findings echo earlier research showing weak or inconsistent links between THC blood levels and crash risk. Large epidemiological studies have found that while marijuana use may slightly increase collision risk, the effect is far smaller than that of alcohol use. “One of the primary problems with using THC concentrations in per se legislation is that the pharmacokinetics of THC are much different from ethanol,” the researchers wrote. The authors noted that alcohol generally cannot be detected 1 to 2 days after last ingestion, whereas THC can be measured up to 30 days after last use because of its lipophilic nature. To generate the data, researchers studied 190 heavy consumers who were instructed to abstain for 48 hours. Following that several day period, the participants’ blood THC concentrations were measured both before and after cannabis consumption to establish baselines. They were also observed using a driving simulator. “Current cannabis blood concentrations used to identify impaired drivers could land innocent people in jail,” the Association for Diagnostics & Laboratory Medicine, which publishes the journal that the study appeared in, said in a press release. “Cannabis blood limit laws lack scientific credibility and are not an accurate determinant of when drivers should face criminal charges or not.” The authors of the study concluded that “more work needs to be done to address how to best identify drivers who are under the influence of cannabis and are unsafe to drive.” “Despite evidence showing no correlation between the detection of THC in the blood and driving impairment, 6 states in the United States have per se laws using 2 or 5 ng/mL of THC as the cut-off point for driving under the influence of cannabis, while 12 have a zero-tolerance law,” the journal’s press release says. The authors, affiliated with the University of California, San Diego and the Center for Medicinal Cannabis Research cautioned that additional research is needed, saying “at present, the best protocol is a combination of observations in the field and toxicology testing.” A separate study last year found “no support that marijuana legalization increased tolerant behaviors and attitudes toward driving after marijuana use.” Authored by researchers at Nationwide Children’s Hospital and Ohio State University, the study used data from a national traffic safety survey. Earlier this year, President Donald Trump’s now-confirmed nominee to lead a key federal traffic safety agency said he’s prepared to “double down” on increasing awareness about the risk of marijuana-impaired driving in partnership with the White House. The post Marijuana Users Are Being Unjustly Jailed For Allegedly Driving Under The Influence, Government-Funded Study Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

При создании аккаунта на официальном сайте 1xBet есть поле «Промокод» — туда нужно ввести специальный код как ввести промокод в 1xbet

California officials have awarded nearly $30 million in grants for marijuana-focused academic research projects. The government-funded studies will focus on issues such as cannabis use by older people, the effects of THC beverages, the therapeutic potential of novel cannabinoids, how compounds like terpenes affect product flavoring, tribal participation in the legal market and the environmental impact of marijuana licensing programs. This marks the third round of grants delivered through the program—which is funded by marijuana tax revenue—raising the total distributions to about $80 million. The Department of Cannabis Control (DCC) said it prioritized proposals in research areas including educational methods of improving public health and safety, crop yields, state and local marijuana policies, consumer preferences, environmental sustainability and other topics. “All research findings will be made available at no cost to the public to support broad access to rigorous, science-backed research while contributing to the national understanding of cannabis,” the department said in a press release on Monday. “DCC received 149 proposals,” it said. “Funding decisions were based on researchers demonstrating strong scientific methodologies, the potential of their research to improve public understanding of cannabis and its effects, and to inform future policymaking.” Here are some examples of grant awardees and their research initiatives: UC San Diego: Cannabis Use and Product Selection Among Older Adults. This study seeks understanding of how older adults weigh product features like potency, cost, and safety when purchasing cannabis. Findings will inform labeling, education, and retail strategies to improve consumer safety and support evidence-based cannabis policy for aging populations. ($643,428) UC San Francisco: Clinical pharmacology of commercially available THC-infused beverages. This study will measure THC absorption, onset, and duration across multiple infused-beverage formulations under real-world consumption conditions. Results will inform product safety standards, labeling accuracy, and consumer guidance for low-dose beverage products to minimize impairment risks. ($1,975,523.03) UC Davis: Pathways to Partnership with the Tribal Cannabis Market. This study will examine California’s tribal cannabis markets and identify models for tribal–state collaboration. The project will produce regulatory templates and partnership pathways to enhance consumer safety, environmental sustainability, and economic opportunities while respecting tribal sovereignty. ($698,537) UC San Francisco: Cannabinoids and the brain: Focused investigations of therapeutic application and early-life risk. This project will examine how exposure to specific cannabinoids affects brain development, neuroinflammation, and therapeutic pathways. The work will clarify safe dosage thresholds and long-term neurological risks, advancing cannabinoid-based medicine and public health protection. ($1,993,986.41) UC Los Angeles: Cannabinoid Therapeutics: Synthesis, Binding, Safety, and Computations. This project will study and characterize novel cannabinoids with therapeutic potential. ($2,000,000) UC San Diego: Price and Tax Trends and Their Effects on Cannabis Sales: Evidence from Multi-State Retail Scanner Data. Using comprehensive retail scanner data across 20+ U.S. states, this project will analyze consumer responsiveness to price changes and tax rates, providing actionable insights to guide equitable, health-oriented taxation policies. ($1,219,052) UC Berkeley: Cannabis Crop Yields: Survey & Remote Sensing. This project will estimate cannabis crop yield variability across indoor, outdoor, and mixed-light cultivation systems. The resulting models will improve crop-production estimates and inform regulatory oversight and market forecasting for California’s legal cannabis sector. ($1,807,977) UC Los Angeles: Characterization of Naturally Occurring Organoleptic Compounds for Inhalable Cannabis Regulation. This study will build a Flower Flavor-Compound Reference Dataset defining natural terpene concentration ranges to distinguish authentic plant flavors from prohibited additives, supporting DCC policy and consumer safety. ($1,234,746) San Diego State: Pesticide and Allergen Exposure Among Cannabis Workers: An Occupational Health Study. Through a community-based field study of 150 participants, this research uses silicone wristbands for passive chemical sampling and advanced analysis to assess pesticide and terpene exposure among cannabis workers across cultivation types. Results will provide the first comprehensive exposure profile for California’s cannabis workforce, guiding occupational health protections and regulatory enforcement. ($1,157,196) UC Berkeley: Assessing the Environmental Benefits of Cannabis Licensure. This study compares licensed and unlicensed cultivation sites to quantify improvements in water, habitat, and pesticide management following licensure. ($731,754) One of the earlier rounds, in 2023, focused on studies investigating novel cannabinoids like delta-8 THC, the genetics of “legacy” strains from the state and monopolies and unfair competition in the market. Meanwhile, in May, the Governor’s Office of Business and Economic Development (GO-Biz) announced the recipients of over $52 million in community reinvestment grants to nonprofits and local health departments, also funded by marijuana tax revenue. That marked the seventh round of cannabis-funded California Community Reinvestment Grants (CalCRG) under the state program. Legalization in California has created a number of new grant programs aimed at addressing the consequences of marijuana prohibition and attempting to nurture a strong, well-regulated legal industry. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, in October the governor of California vetoed a bill that would have allowed certain marijuana microbusinesses to ship medical cannabis products directly to patients via common carriers like FedEx and UPS, stating that the proposal “would be burdensome and overly complex to administer.” Also that month, Gov. Gavin Newsom (D) signed a bill aimed at streamlining research on marijuana and psychedelics. In September, the governor also signed legislation into law to put a pause on a recently enacted tax hike on marijuana products. The post California Officials Award $30 Million In Marijuana Revenue To Support Research On THC Drinks, Terpenes And Tribal Cannabis Sales appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

As 2025 comes to a close, the cannabis world is reflecting on the sometimes dizzying series of political, legal and cultural shifts that took place this year—and looking ahead to further developments that advocates and industry stakeholders will be navigating in the new year. Top of mind, of course, is President Donald Trump’s executive order this month directing the attorney general to complete the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA), marking perhaps the most significant administrative cannabis action in U.S. history. But from the White House to the U.S. Supreme Court to state legislatures across the country, there were additional meaningful marijuana developments this year. That includes the upending of key provisions of federal law that had legalized hemp and its derivatives. What 2026 will bring is yet to be seen. Many eyes will be focused on how the Justice Department approaches the president’s rescheduling directive, but some see opportunities for further reform—with optimism that there’s momentum to see through a bipartisan banking bill, for example. And hopes are high that additional states could legalize cannabis in 2026—though advocates are also preparing to fight prohibitionist efforts to roll back wins that have already been achieved in other states. Looking back at 2025, here are the top marijuana moments: Trump signs marijuana rescheduling executive order After campaigning on a promise to reschedule marijuana ahead of his second term–and months of relative silence on cannabis issues after taking office—Trump in December signed an executive order directing the attorney general to expeditiously complete the process of moving cannabis to Schedule III. The reform hasn’t been finalized yet, but if it is, the policy change would mark one of the most substantial changes to federal marijuana laws since its prohibition over half a century ago. Rescheduling wouldn’t legalize the plant, but it would recognize its medical value, allow marijuana businesses to take federal tax deductions and loosen certain research barriers. In addition to rescheduling, Trump administration announces policy to expand access to CBD Trump’s executive order also urged Congress to examine updating the definition of hemp to ensure that full-spectrum CBD is accessible to patients. If lawmakers do so, it could mitigate some concerns in the sector about a recent spending bill the president signed with provisions that would broadly ban consumable hemp products. A further redefinition of hemp would be part of a novel proposal to allow Medicare recipients to access non-intoxicating CBD that’d be covered under the federal health care plan. U.S. Supreme Court declines to take landmark case challenging prohibition Advocates and stakeholders were handed a defeat from the Supreme Court in December after justices declined to accept a case challenging the constitutionality of federal marijuana prohibition—an issue that even one of the bench’s more conservative members, Justice Clarance Thomas, had previously argued must be resolved amid the state legalization movement. Massachusetts-based marijuana businesses had asked the court to take their case because they argued that federal law unconstitutionally prohibits intrastate cannabis activity, contravening the Commerce Clause. Justices weigh federal gun ban for marijuana consumers In October, meanwhile, the Supreme Court agreed to hear a case on the constitutionality of a federal law prohibiting people who use marijuana or other drugs from buying or possessing firearms. The Trump administration has argued that the policy “targets a category of persons who pose a clear danger of misusing firearm” and should be upheld. Trump signs spending bill with hemp ban provisions In November, the president signed appropriations legislation that includes provisions to ban most consumable hemp products that have proliferated since the crop was legalized under the 2018 Farm Bill that Trump signed during his first term in office. The hemp components won’t be implemented until one year after enactment, however, and stakeholders and certain lawmakers say that window could provide an opportunity to advance legislation to create an alternative regulatory model for cannabinoid products. Congressional lawmakers file cannabis bills and hold hearings on various marijuana issues A slew of cannabis bills were filed or refiled for the 119th Congress in 2025, including those that would federally legalize marijuana, take steps to prepare for the eventual end of prohibition, stop the implementation of a federal hemp THC product ban, prevent people from using federal financial assistance at marijuana dispensaries, protect military veterans from losing government benefits for using medical cannabis in compliance with state law and more. None of those measures advanced to enactment, though lawmakers did approve amendments to a spending bill that would have authorized U.S. Department of Veterans Affairs (VA) doctors to issue medical marijuana recommendations to military veterans and support psychedelics research and access. Even though versions of the veterans’ medical cannabis amendment were approved by both the House of Representatives and Senate, the reform was stripped out of a final spending bill sent to the president. And while there’s been disappointment about the lack of progress on cannabis industry banking issues, a Senate subcommittee did take up the subject at a hearing in December that featured a former state marijuana regulator as a witness. Trump administration rescinds Biden-era marijuana enforcement guidance The Trump administration quietly rescinded guidance implemented under former President Joe Biden that ordered U.S. prosecutors to be “extremely cautious” about how to handle cannabis cases. In November, the U.S. Attorney’s Office for the District of Wyoming disclosed that the guidance was rescinded in September, and it said cases involving marijuana would consequently be “rigorously” enforced on federal land. Federal immigration officials raid California marijuana business Marijuana farms operated by a major state-licensed business in California were raided by federal officials in July. The action didn’t appear to be a targeted effort by the federal government against the state-legal cannabis industry specifically, as other reports indicated that Immigration and Customs Enforcement (ICE) agents had been involved in numerous enforcement actions in the area at the time. American medical cannabis patient released from Russian prison after possession conviction An American who was released from a Russian prison over marijuana possession he obtained as a lawful medical cannabis patient in Pennsylvania was among President Donald Trump’s invited guests at a speech before a joint session Congress on in March. Marc Fogel—who was serving a 14-year sentence in Russian after being convicted of “drug smuggling” over possession of a half-ounce of cannabis and whose release was secured as part of a prisoner swap—was in attendance at the president’s speech on Capitol Hill. Vice President JD Vance and U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. participate in conference with psychedelics panel Vance, Kennedy, Food and Drug Administration (FDA) Commissioner Marty Makary and other top Trump administration officials attended a “Make America Healthy Again” summit that featured a session on the therapeutic potential of psychedelics. Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services (CMS), and Katie Miller, wife of Trump adviser Stephen Miller, were also among those who attended the event, which was meant to broadly showcase the MAHA agenda and areas of innovation in public health. State-level legalization efforts gain momentum Although no additional states enacted cannabis legalization laws in 2025, reform legislation did advance—demonstrating momentum that advocates hope to build upon in 2026. The Pennsylvania House of Representatives in March passed a bill to legalize marijuana sales through a novel system of state-owned dispensaries, but it was rejected in the GOP-controlled Senate. Two Hawaii Senate panels in February approved a broad bill that would legalize adult-use marijuana and bring together hemp and cannabis regulation under a single state agency. Also, the full Senate gave approval to a bill that would, among other changes, allow healthcare providers to recommend cannabis to treat any condition they believe it would benefit. The New Hampshire House of Representatives approved bills to legalize marijuana, decriminalize the use and possession of psilocybin by adults and double the amount of medical cannabis that state-registered patients can purchase and possess. The Virginia legislature approved legislation to legalize adult-use cannabis sales, only to have it once again vetoed by the governor. Marijuana sales launch in Delaware, Minnesota and Kentucky Adult-use marijuana sales began in Delaware and Minnesota in 2025, while medical cannabis dispensaries opened their doors in Kentucky. States impose hemp bans amid concerns over intoxicating cannabinoid products As congressional lawmakers moved to recriminalize certain hemp products, red and blue states—from Texas to Ohio to California—took steps on their own to restrict the sale of consumable cannabinoids. Virginia elects pro-cannabis governor as legislative commission unveils legalization plan Efforts to legalize adult-use marijuana sales in Virginia got a boost with the election of Abigail Spanberger as the state’s next governor. And the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market subsequently unveiled a much-anticipated proposal to legalize recreational marijuana sales that it is recommending lawmakers pass during the 2026 session. Florida campaign makes another run to legalize adult-use marijuana through the ballot The campaign Smart & Safe Florida filed a new cannabis legalization initiative that they hope will go before voters next November. And after collecting what they estimated to be more than one million signatures to secure ballot placement amid litigation, Florida’s attorney general asked the state Supreme Court to review the constitutionality of the proposal. Anti-marijuana activists plot to undermine state legalization laws In three states—Arizona, Maine and Massachusetts—prohibitionist activists have made moves to put initiatives on the ballot next year to roll back key components of adult-use legalization laws, focusing largely on the elimination of the commercial market. More developments arise in state-level drug policy ballot campaigns An Idaho campaign unveiled a since-certified initiative to put medical marijuana legalization on the state’s 2026 ballot. In Oregon, activists withdrew a ballot proposal to legalize marijuana social consumption lounges. And in Alaska, a campaign said it failed to collect enough signatures to put an initiative to legalize certain psychedelics such as psilocybin and DMT on the ballot next year—but activists emphasized that the “work is far from over” as they shift focus to placing the reform measure before voters in 2028. New York marks milestones in marijuana market expansion After a rocky rollout of the state’s adult-use marijuana law, marred by lawsuits and regulatory complications, New York officials in November celebrated the opening of its 500th legal cannabis dispensary—touting the fact that there have been $2.3 billion in sales since the market launched, supporting an estimated 25,000 jobs across the industry. States move forward with psychedelics reform Over the summer, Texas Gov. Greg Abbott (R) signed into law a bill to create a state-backed research consortium to conduct clinical trials on ibogaine as a possible treatment for substance use disorders and other mental health conditions. And in Arizona, officials approved and funded a first-in-the-nation clinical trial investigating the potential of whole mushroom psilocybin to treat post-traumatic stress disorder (PTSD) in first responders and military veterans. New Jersey gubernatorial election raises hopes for reform New Jersey voters elected U.S. Rep. Mikie Sherrill (D-NJ) to serve as the state’s next governor, meaning there’s now a decidedly clearer path to advancing a marijuana policy reform long awaited by consumers and advocates in the Garden State: A home grow option. Target launches pilot program for hemp beverage sales In one of the latest examples of the normalization of cannabis in mainstream commercial marketing, the retail giant Target soft launched sales of THC-infused beverages at select stores in Minnesota. Edible Arrangements offshoot embraces the hemp industry The company behind Edible Arrangements is entering the cannabis market, launching a new delivery service for hemp products. Edible Brands, best known for its line of ornate fruit arrangements, announced in March that it was expanding to start selling different kinds of edibles: hemp gummies, drinks and supplements. Photo courtesy of Philip Steffan. The post Marijuana Saw Some Big Moments In 2025—From Trump’s Rescheduling Order To State Legalization Momentum appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Texas health officials have released a set of proposed rules to regulate the state’s hemp market—including provisions related to age-gating, licensing fees, testing requirements, packaging restrictions and more in response to an executive order the governor signed in September. The proposal would also shift hemp to a total THC standard, rather than the current one that limits delta-9 THC content alone, which advocates say will eliminate some popular products from the market. Various state agencies have been taking steps to align their policies with the governor’s order, and now the Department of State Health Services (DSHS) is outlining its plan to expand and codify hemp rules in a notice published in the Texas Register on Friday. One of the more significant provisions makes it so consumable hemp products could not be sold to people under 21. That policy is already in place under an emergency rule the agency adopted in October, so officials are now seeking to finalize it. There would also be increased licensing fees for hemp businesses under the rules, which DSHS CFO Christy Havel Burton said would mean the industry “may incur economic costs” in the first five years of implementation. “Some retailers and manufacturers may incur costs associated with compliance with age verification requirements, depending on the methodology and equipment used to verify identification and to ensure minors are not sold consumable hemp products,” she said. The rule—which is open to public comment until January 26—would also prohibit transporting products containing more than 0.3 percent THC into Texas for additional processing and require hemp products to be secured in packaging that’s “tamper-evident, child-resistant and non-attractive to children.” State code would additionally be amended to explicitly prohibit labeling cannabis products in a way that misleads consumers “to believe products do not contain hemp-derived cannabinoids or are intended for medical use,” the notice says. There are also a series of more technical policy changes related to product tracking, record-keeping, recall procedures and testing requirements. While hemp businesses may incur financial costs to get into compliance with the new rule, an economic estimate included in the notice says the government would see an increase in revenue of about $202 million for the first five years after it takes effect. Timothy Stevenson, deputy commissioner of DSHS’s Consumer Protection Division, additionally said that “the public benefit will be increased public health requirements for the manufacturers, distributors, and retailers of CHPs along with prohibited availability and access of CHPs to minors.” A public hearing on the proposed rules is scheduled for January 9. Heather Fazio of the Texas Cannabis Policy Center said in an email to supporters that the rules “include some important, long-overdue consumer protections,” but she also cautioned that in other ways the proposal “raises serious concerns.” She said the fee increases for operators are “dramatic” and “would place enormous strain on small businesses, micro-businesses, and rural retailers.” The shift to a total THC standard, meanwhile, “would effectively eliminate hemp flower from the legal market,” Fazio said. “Removing regulated access to the most common and least processed hemp product does not eliminate demand—it pushes consumers into unregulated markets with no testing, no age checks, and no consumer protections,” she said. (Disclosure: Fazio supports Marijuana Moment’s work with a monthly pledge on Patreon.) After the governor issued the emergency order barring hemp sales, the Texas Alcoholic Beverage Commission (TABC) separately put forward temporary emergency rules to codify the policy change—and earlier this month it released plans to adopt an amended regulation on the issue permanently after receiving public and stakeholder input. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, state officials with the Department of Public Safety (DPS) separately conditionally approved nine new medical marijuana business licenses this month as part of a law that’s being implemented to significantly expand the state’s cannabis program. The department will issue conditional licenses to three additional dispensaries by April 2026. This represents a major change to the program, as there are currently only three dispensaries licensed to operate in Texas. DPS in October adopted additional rules to increase the number of licensed dispensaries, establishing security requirements for “satellite” locations and authorizing the revocation of licenses for certain violations. DSHS also recently finalized rules allowing doctors to recommend new qualifying conditions for cannabis patients and creating standards for allowable low-THC inhalation devices. For what it’s worth, a survey from a GOP pollster affiliated with President Donald Trump found that Texas Democratic and Republican voters are unified in their opposition to the hemp ban proposal. Image element courtesy of AnonMoos. The post Texas Officials Invite Comment On New Hemp Rules Covering Age Limits, Licensing Fees, Labeling And More appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Awesome posting, it has the such a interesting site there is listed here, keep up to date favorable deliver the results, might be backside. how does john spencer ellis help you build a sustainable business model